Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B4

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6148-6154

  Matsukawa, Akihiro ^a   Hogaboam, Cory M ^a   Lukacs, Nickolas W ^a   Lincoln, Pamela M ^a   Strieter, Robert M ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; ANTIBODY; CHEMOKINE; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LEUKOCYTE MIGRATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEPSIS; SURVIVAL;

ANIMALS; ASCITIC FLUID; BENZOPYRANS; CARBOXYLIC ACIDS; CECUM; CHEMOKINE CCL2; CHEMOKINES; FEMALE; LEUKOTRIENE B4; MICE; PERITONEAL CAVITY; PERITONITIS; RECEPTOR CROSS-TALK; RECEPTORS, LEUKOTRIENE B4; SEPSIS;

EID: 0033485754     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Astiz, M. E., and E. C. Rackow. 1998. Septic shock. Lancet 351:1501.
2. Parrillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227.
3. Holzheimer, R. G., K. H. Muhrer, N. L'Allemand, T. Schmidt, and K. Henneking. 1991. Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 19:447.
4. Heemken, R., L. Gandawidjaja, and T. Hau. 1997. Peritonitis: pathophysiology and local defense mechanisms. Hepatogastroenterology 44:927.
5. Klebanoff, S. J., and R. A. Clark. 1978. The Neutrophils: Functional and Clinical Disorders. North-Holland, New York.
6. Keller, R., R. Gehri, R. Keist, E. Huf, and F. H. Kayser. 1991. The interaction of macrophages and bacteria: a comparative study of the induction of tumoricidal activity and of reactive nitrogen intermediates. Cell. Immunol. 134:249.
7. Luster, A. D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
8. Frohlich, D., R. M. Eiber, M. Jochum, and A. Billing. 1997. Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-α, and granulocyte elastase release in human secondary peritonitis. Cytokine 9:288.
9. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1997. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65:3847.
10. Yoshimura, T., and A. Ueda. 1996. Monocyte chemoattractant protein-1. In Human Cytokines II: Handbook for Basic and Clinical Research. B. B. Aggarwal, and J. U. Gutterman, eds. Blackwell Scientific publications, Oxford, U.K., p. 198.
11. Hack, C. E., L. A. Aarden, and L. G. Thijs. 1997. Role of cytokines in sepsis. Adv. Immunol. 66:101.
12. Bossink, A. W., L. Paemen, P. M. Jansen, C. E. Hack, L. G. Thijs, and J. Van Damme. 1995. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86:3841.
13. Jansen, P. M., J. van Damme, W. Put, I. W. de Jong, F. B. Taylor, Jr., and C. E. Hack. 1995. Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons. J. Infect. Dis. 171:1640.
14. Sylvester, I., A. F. Suffredini, A. J. Boujoukos, G. D. Martich, R. L. Danner, T. Yoshimura, and E. J. Leonard. 1993. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum: effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J. Immunol. 151:3292.
15. Fink, M. P., and S. O. Heard. 1990. Laboratory models of sepsis and septic shock. J. Surg. Res. 49:186.
16. Hogaboam, C. M., M. L. Steinhauser, H. Schock, N. W. Lukacs, R. M. Strieter, T. J. Standiford, and S. L. Kunkel. 1998. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect. Immun. 66:650.
17. Zisman, D. A., S. L. Kunkel, R. M. Strieter, W. C. Tsai, K. Bucknell, J. Wilkowski, and T. J. Standiford. 1997. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99:2832.
18. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790.
19. Karpus, W. J., K. J. Kennedy, S. L. Kunkel, and N. W. Lukacs. 1998. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 187:733.
20. -/- mice: the role of mast cells. J. Immunol. 163:2160.
21. 4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 92:517.
22. 4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J. Exp. Med. 183:1893.
23. Fisher, C. J., Jr., J. M. Agosti, S. M. Opal, S. F. Lowry, R. A. Balk, J. C. Sadoff, E. Abraham, R. M. H. Schein, and E. Benjamin. 1996. Treatment of septic shock with the tumor necrosis factor receptor:fc fusion protein: the soluble TNF receptor sepsis study group. N. Engl. J. Med. 334:1697.
24. Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148:2724.
25. O'Reilly, M., G. M. Silver, J. H. Davis, R. L. Gamelli, and J. C. Hebert. 1992. Interleukin 1β improves survival following cecal ligation and puncture. J. Surg. Res. 52:518.
26. Fisher, C. J., Jr., J. F. Dhainaut, S. M. Opal, J. P. Pribble, R. A. Balk, G. J. Slotman, T. J. Iberti, E. C. Rackow, M. J. Shapiro, R. L. Greenman, et al. 1994. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. J. Am. Med. Assoc. 271:1836.
27. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485.
28. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112.
29. Nakano, Y., T. Kasahara, N. Mukaida, Y. C. Ko, M. Nakano, and K. Matsushima. 1994. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect. Immun. 62:377.
30. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, J. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1449.
31. 4. Int. J. Biochem. Cell Biol. 30:173.
32. 4 and f-Met-Leu-Phe. Am. J. Pathol. 127:157.
33. 4. Int. J. Immunopharmacol. 11:801.
34. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. M. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 154:5221.